Chat with us, powered by LiveChat
Micro Market Research
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     PAYMENT LINK _ Drug Discovery Services Market by Process (Target Selection, Hit-to-Lead Identification, Lead Optimization), Type (Medicinal Chemistry, Biology Services, DMPK), Drug Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, Neurology) - Forecast to 2022    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

European Drug Delivery Devices Market Research Report

  • Report Code: DR 1002
  • Publish Date: Upcoming
Table of Contents
Customer Intelligence
Inquiry Before Buying Ask for Discount

The European drug delivery devices market was valued at $45 billion in 2013, and expected to reach $63 billion by 2018, at a CAGR of 8.3%. The oral delivery devices market is the fastest-growing segment of the $28 billion drug delivery devices market.


The report ‘European Drug Delivery Devices Market Forecast, 2012-2018’ analyzes the market of drug delivery devices by nine technologies, such as oral, transdermal, respiratory, injectable, implantable, transmucosal, nasal, ocular, and topical drug delivery devices. Oral drug delivery dominates the market as it is the most convenient route of administration and controlled release. This sub-segment is a traditional and easy to adopt technology, with minimum manufacturing settings. In addition, the demand and use of orodispersible tablets (ODT) is on a rise for pediatric and geriatric patients. These factors have contributed to the large size of the oral drug delivery technology market.


In Europe (Germany, France, Italy, Spain, UK), the key driver of the European drug delivery technology market is the large investment in R&D in this market. In addition, the centralized approval process through the European Medicines Agency (EMA) enable pharmaceutical companies to sell their products in EU-27 nations. This encourages drug delivery technology and pharmaceutical companies introduce their products in the region. Due to certain amount of saturation in the market, Europe is expected to grow at a slower speed.


The report also provides an extensive competitive landscaping of companies operating in this market. The main companies operating in this market and extensively covered in this report are SkyePharma Plc (U.K.), Ypsomed Holding AG (Switzerland), and GSK (U.K.) Segment and country-specific company shares, news & deals, mergers and acquisitions, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.


Customization Options


Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:


Product Analysis

  • Usage pattern (in-depth trend analysis) of products (segment wise)
  • Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
  • Applications of the products (segment wise and country wise)
  • Comprehensive coverage of product approvals, pipeline products, and product recalls


Epidemiology Data

  • Country-specific prevalence of chronic diseases
  • Country-specific Patient pool of chronic disease population
  • Disease progression (pattern analysis)


Surgeons/Physicians Perception Analysis

  • Fast turn-around analysis of surgeons’ response to market events and trends
  • Pattern analysis of usage of therapy devices wound care products by physicians
  • Surgeons’ opinion about products from different companies
  • Surgeons’ qualitative inputs on epidemiology data


Brand/Product Perception Matrix

  • Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
  • Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)


Pricing Trend

  • Cost analysis of products in various countries

1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)


2 Executive Summary

3 Market Overview

4 Drug Delivery Devices-Europe, by Segments
4.1 Injectables Drug Delivery devices-Europe
4.1.1 Injectables Drug Delivery devices-Europe, by Companies Injectables Drug Delivery devices-Gerresheimer AG-Europe Injectables Drug Delivery devices-Becton Dickinson & Company-Europe Injectables Drug Delivery devices-Amcor Limited-Europe Injectables Drug Delivery devices-Meadwestvaco Corporation-Europe Injectables Drug Delivery devices-Schott AG-Europe Injectables Drug Delivery devices-AptarGroup, Inc.-Europe

Please fill in the form below to receive a free copy of the Summary of this Report

European Drug Delivery Devices Market Research Report

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit to specify your custom Research Requirement
Brazil Medical Devices Brazil Medical Devices
Peers of Brazil medical devices are Orthopedic Devices, Ophthalmology devices, Endoscopy and Neurology Devices comprising 12.8%, 9.2%, 7.2% and 1.9% respectively of the Global Medical Devices market. It is segmented on basis of endusers and...
Nov 2015
of items
reports | Show
Connect With Us
US/CAN : +1-888-502-0539